Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

J App Pharm Sci. 2018; 8(1): 159-164


Effect of bee venom phonophoresis in obese polycystic ovarian women: A Single Blind Randomized Controlled Trial

Maram M. Yasin, Eman A. Elhosary, Hamada Ahmed Hamada, Amel M. Yousef, Mohamed Shahin, Dalia Mosaad.




Abstract

Abstract
Polycystic ovary syndrome (PCOS) is a complex disorder that adversely affect fertility. The purpose of this study was to determine the effect of bee venom (BV) phonophoresis in the treatment of obese PCOS women. Forty-six obese PCOS women with age range, 18- 39 years and body mass index 29- 43 kg/m2 were recruited. Participants were assigned randomly into two equal groups; group A, 23 PCOS patients received phonophoresis with BV topical application in addition to low caloric diet (1200-1400 kcal /day) and group B (control group), 23 PCOS patients followed low caloric diet (1200-1400 kcal /day) and sham ultrasound sessions with plain gel without BV. Assessment was done by biochemical analysis of luteinizing hormone (LH), follicle stimulating hormone (FSH), LH/FSH ratio, and progesterone (P4) levels, measured before, after 7 weeks, and after 14 weeks of treatment. Forty-six obese PCOS women (group A n=23; group B n=23) were randomized and analyzed. Comparison between groups revealed that there was no significance difference between both groups after 7 weeks and after 14 weeks of treatment except for P4 that showed a significant increase in group A after 7 weeks of treatment and marked decrease in LH and LH/FSH ratio in the middle of treatment at group A. BV phonophoresis with diet and physical activity have beneficial effect in the treatment of obese PCOS women.

Key words: Polycystic ovary syndrome, Phonophoresis, Bee venom.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.